Clinical Trial Update: A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating PROSTVAC-V and PROSTVAC-F vaccines with GM-CSF in prostate cancer patients with PSA progression after local therapy. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• PROSTVAC-F (Fowlpox)/TRICOM
• PROSTVAC-V (Vaccinia)/TRICOM

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Prostate Carcinoma, Stage I Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-04